Literature DB >> 25446628

Core outcomes and definitions for pediatric fever and neutropenia research: a consensus statement from an international panel.

Gabrielle M Haeusler1, Robert S Phillips, Thomas Lehrnbecher, Karin A Thursky, Lillian Sung, Roland A Ammann.   

Abstract

BACKGROUND: There are no specific recommendations for the design and reporting of studies of children with fever and neutropenia (FN). As a result, there is marked heterogeneity in the variables and outcomes that are reported and new definitions continue to emerge. These inconsistencies hinder the ability of researchers and clinicians to compare, contrast and combine results. The objective was to achieve expert consensus on a core set of variables and outcomes that should be measured and reported, as a minimum, in pediatric FN studies. PROCEDURE: The Delphi method was used to achieve consensus among an international group of clinicians, pharmacists, researchers, and patient representatives. Four surveys focusing on (i) the identification of a core set of variables and outcomes; and (ii) definitions of these variables and outcomes, were administered electronically. Consensus was predefined as more than 80% agreement on any statement.
RESULTS: There were forty-five survey participants and the response rate ranged between 84 and 96%. There was consensus on eight core variables and 10 core outcomes that should be collected and reported in all studies of children with FN. Consensus definitions were identified for all of the core outcomes.
CONCLUSION: Using the Delphi method, expert consensus on a set of core variables and outcomes, and their corresponding definitions, was achieved. These core sets represent the minimum that should be collected and reported in all studies of children with FN. This will promote collaboration and ensure consistency and comparability between studies.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  child; consensus; definitions; fever; neutropenia; outcomes

Mesh:

Year:  2014        PMID: 25446628     DOI: 10.1002/pbc.25335

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  25 in total

1.  Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.

Authors:  Christa Koenig; Christine Schneider; Jessica E Morgan; Roland A Ammann; Lillian Sung; Bob Phillips
Journal:  Support Care Cancer       Date:  2019-07-01       Impact factor: 3.603

2.  Blood transcriptomics identifies immune signatures indicative of infectious complications in childhood cancer patients with febrile neutropenia.

Authors:  Gabrielle M Haeusler; Alexandra L Garnham; Connie Sn Li-Wai-Suen; Julia E Clark; Franz E Babl; Zoe Allaway; Monica A Slavin; Francoise Mechinaud; Gordon K Smyth; Bob Phillips; Karin A Thursky; Marc Pellegrini; Marcel Doerflinger
Journal:  Clin Transl Immunology       Date:  2022-05-17

3.  The Golden Hour: Sustainability and Clinical Outcomes of Adequate Time to Antibiotic Administration in Children with Cancer and Febrile Neutropenia in Northwestern Mexico.

Authors:  Miriam L Gonzalez; Paula Aristizabal; Adriana Loera-Reyna; Dara Torres; Mario Ornelas-Sánchez; Laura Nuño-Vázquez; Marco Aguilera; Alicia Sánchez; Mitzy Romano; Rebeca Rivera-Gómez; George Relyea; Paola Friedrich; Miguela A Caniza
Journal:  JCO Glob Oncol       Date:  2021-05

Review 4.  Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?

Authors:  Arne Simon; Rhoikos Furtwängler; Norbert Graf; Hans Jürgen Laws; Sebastian Voigt; Brar Piening; Christine Geffers; Philipp Agyeman; Roland A Ammann
Journal:  GMS Hyg Infect Control       Date:  2016-05-12

5.  Antibiotic-Resistant Gram-Negative Bacteremia in Febrile Neutropenic Children.

Authors:  Jina Lee
Journal:  Infect Chemother       Date:  2016-09

Review 6.  Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys.

Authors:  Beth K Potter; Brian Hutton; Tammy J Clifford; Nicole Pallone; Maureen Smith; Sylvia Stockler; Pranesh Chakraborty; Pauline Barbeau; Chantelle M Garritty; Michael Pugliese; Alvi Rahman; Becky Skidmore; Laure Tessier; Kylie Tingley; Doug Coyle; Cheryl R Greenberg; Lawrence Korngut; Alex MacKenzie; John J Mitchell; Stuart Nicholls; Martin Offringa; Andreas Schulze; Monica Taljaard
Journal:  Trials       Date:  2017-12-19       Impact factor: 2.279

7.  Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study.

Authors:  Gabrielle M Haeusler; Karin A Thursky; Francoise Mechinaud; Franz E Babl; Richard De Abreu Lourenco; Monica A Slavin; Robert Phillips
Journal:  Br J Cancer       Date:  2017-06-13       Impact factor: 7.640

8.  Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.

Authors:  Joshua Wolf; Li Tang; Patricia M Flynn; Ching-Hon Pui; Aditya H Gaur; Yilun Sun; Hiroto Inaba; Tracy Stewart; Randall T Hayden; Hana Hakim; Sima Jeha
Journal:  Clin Infect Dis       Date:  2017-11-13       Impact factor: 9.079

9.  Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis.

Authors:  Robert S Phillips; Lillian Sung; Roland A Ammann; Richard D Riley; Elio Castagnola; Gabrielle M Haeusler; Robert Klaassen; Wim J E Tissing; Thomas Lehrnbecher; Julia Chisholm; Hana Hakim; Neil Ranasinghe; Marianne Paesmans; Ian M Hann; Lesley A Stewart
Journal:  Br J Cancer       Date:  2016-03-08       Impact factor: 7.640

10.  Emergency Department Chief Complaints Among Children With Cancer.

Authors:  Megan D Burcham; Anneli R Cochrane; Seethal A Jacob; Aaron E Carroll; Emily L Mueller
Journal:  J Pediatr Hematol Oncol       Date:  2018-08       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.